India"s pharmaceutical market has achieved a significant milestone, with domestic sales reaching Rs 2.25 lakh crore in the 12 months leading up to September 2024. Despite a slowdown in growth rates, the market continues to exhibit strong expansion, making it a crucial sector for pharmaceutical companies.
In the September 2024 quarter, sales rose to Rs 60,000 crore, marking an 8 percent increase compared to the same period last year. This growth is noteworthy when compared to the pre-pandemic December 2019 quarter, which recorded sales of Rs 38,200 crore, highlighting the sector"s resilience and sustained demand.